Expand RPRX Menu
RPRX MENU

RPRX Latest Press Releases

-- September 4, 2026 --

Royalty Pharma announces update on Novartis' Phase 3 topline results for pelacarsen Globe Newswire 7:05 PM

-- August 12, 2026 --

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million Globe Newswire 4:10 PM
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Globe Newswire 4:05 PM

-- August 5, 2026 --

Royalty Pharma reports second quarter 2026 results Globe Newswire 7:00 AM

-- August 3, 2026 --

Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives Globe Newswire 8:15 AM

-- July 22, 2026 --

Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune Globe Newswire 7:05 AM

-- July 17, 2026 --

Royalty Pharma declares third quarter 2026 dividend Globe Newswire 4:15 PM

-- July 15, 2026 --

Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 Globe Newswire 4:15 PM

-- June 4, 2026 --

Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 4:15 PM

-- May 7, 2026 --

Royalty Pharma to present at upcoming investor conferences Globe Newswire 4:15 PM

-- May 6, 2026 --

Royalty Pharma reports first quarter 2026 results Globe Newswire 7:00 AM

-- April 21, 2026 --

Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation Globe Newswire 1:00 PM

-- April 17, 2026 --

Royalty Pharma Declares Second Quarter 2026 Dividend Globe Newswire 8:30 AM

-- April 15, 2026 --

Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 Globe Newswire 4:15 PM
Market Data Delayed 15 Minutes